AR Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $577K | Hold |
6,700
| – | – | 0.11% | 99 |
|
|
2026
Q1 | $606K | Hold |
6,700
| – | – | 0.12% | 93 |
|
|
2025
Q4 | $602K | Hold |
6,700
| – | – | 0.12% | 95 |
|
|
2025
Q3 | $660K | Hold |
6,700
| – | – | 0.14% | 90 |
|
|
2025
Q2 | $611K | Hold |
6,700
| – | – | 0.14% | 90 |
|
|
2025
Q1 | $758K | Hold |
6,700
| – | – | 0.17% | 79 |
|
|
2024
Q4 | $708K | Hold |
6,700
| – | – | 0.16% | 82 |
|
|
2024
Q3 | $723K | Hold |
6,700
| – | – | 0.16% | 83 |
|
|
2024
Q2 | $727K | Hold |
6,700
| – | – | 0.18% | 77 |
|
|
2024
Q1 | $884K | Hold |
6,700
| – | – | 0.22% | 71 |
|
|
2023
Q4 | $815K | Hold |
6,700
| – | – | 0.21% | 71 |
|
|
2023
Q3 | $752K | Hold |
6,700
| – | – | 0.21% | 75 |
|
|
2023
Q2 | $976K | Hold |
6,700
| – | – | 0.26% | 66 |
|
|
2023
Q1 | $866K | Hold |
6,700
| – | – | 0.23% | 72 |
|
|
2022
Q4 | $854K | Hold |
6,700
| – | – | 0.24% | 68 |
|
|
2022
Q3 | $700K | Hold |
6,700
| – | – | 0.21% | 80 |
|
|
2022
Q2 | $704K | Hold |
6,700
| – | – | 0.2% | 82 |
|
|
2022
Q1 | $857K | Sell |
6,700
-201
| -3% | -$24.2K | 0.22% | 79 |
|
|
2021
Q4 | $851K | Sell |
6,901
-29
| -0.4% | -$3.79K | 0.22% | 78 |
|
|
2021
Q3 | $985K | Hold |
6,930
| – | – | 0.28% | 70 |
|
|
2021
Q2 | $1.08M | Hold |
6,930
| – | – | 0.3% | 62 |
|
|
2021
Q1 | $1.08M | Hold |
6,930
| – | – | 0.32% | 62 |
|
|
2020
Q4 | $1.04M | Hold |
6,930
| – | – | 0.33% | 60 |
|
|
2020
Q3 | $916K | Hold |
6,930
| – | – | 0.32% | 64 |
|
|
2020
Q2 | $803K | Hold |
6,930
| – | – | 0.3% | 71 |
|
|
2020
Q1 | $680K | Hold |
6,930
| – | – | 0.28% | 77 |
|
|
2019
Q4 | $1.01M | Hold |
6,930
| – | – | 0.34% | 65 |
|
|
2019
Q3 | $924K | Hold |
6,930
| – | – | 0.33% | 70 |
|
|
2019
Q2 | $792K | Hold |
6,930
| – | – | 0.29% | 72 |
|
|
2019
Q1 | $859K | Hold |
6,930
| – | – | 0.32% | 69 |
|
|
2018
Q4 | $698K | Hold |
6,930
| – | – | 0.3% | 69 |
|
|
2018
Q3 | $885K | Hold |
6,930
| – | – | 0.33% | 71 |
|
|
2018
Q2 | $750K | Hold |
6,930
| – | – | 0.29% | 72 |
|
|
2018
Q1 | $734K | Hold |
6,930
| – | – | 0.3% | 73 |
|
|
2017
Q4 | $812K | Hold |
6,930
| – | – | 0.31% | 68 |
|
|
2017
Q3 | $788K | Hold |
6,930
| – | – | 0.31% | 70 |
|
|
2017
Q2 | $864K | Hold |
6,930
| – | – | 0.35% | 66 |
|
|
2017
Q1 | $822K | Hold |
6,930
| – | – | 0.34% | 65 |
|
|
2016
Q4 | $694K | Hold |
6,930
| – | – | 0.3% | 70 |
|
|
2016
Q3 | $875K | Hold |
6,930
| – | – | 0.38% | 64 |
|
|
2016
Q2 | $810K | Hold |
6,930
| – | – | 0.34% | 67 |
|
|
2016
Q1 | $717K | Hold |
6,930
| – | – | 0.31% | 69 |
|
|
2015
Q4 | $690K | Hold |
6,930
| – | – | 0.31% | 71 |
|
|
2015
Q3 | $632K | Hold |
6,930
| – | – | 0.28% | 77 |
|
|
2015
Q2 | $735K | Sell |
6,930
-406
| -6% | -$44.9K | 0.3% | 73 |
|
|
2015
Q1 | $837K | Hold |
7,336
| – | – | 0.34% | 68 |
|
|
2014
Q4 | $808K | Hold |
7,336
| – | – | 0.33% | 67 |
|
|
2014
Q3 | $716K | Hold |
7,336
| – | – | 0.29% | 69 |
|
|
2014
Q2 | $740K | Hold |
7,336
| – | – | 0.3% | 69 |
|
|
2014
Q1 | $674K | Hold |
7,336
| – | – | 0.28% | 71 |
|
|
2013
Q4 | $664K | Hold |
7,336
| – | – | 0.28% | 69 |
|
|
2013
Q3 | $585K | Hold |
7,336
| – | – | 0.26% | 72 |
|
|
2013
Q2 | $534K | Buy |
+7,336
| New | +$549K | 0.24% | 76 |
|
Other funds holding ZBH
VCM
VPM
AR Asset Management's ZBH Position: Q2 2026 in Review
AR Asset Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 6,700 shares worth $577K. The position accounts for 0.11% of the portfolio, ranked #99.
AR Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.08M in Q2 2021. 771 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- AR Asset Management held 6,700 shares of Zimmer Biomet worth $577K as of Q2 2026.
- AR Asset Management left its Zimmer Biomet share count unchanged in Q2 2026.
- Zimmer Biomet made up 0.11% of AR Asset Management's portfolio in Q2 2026, its #99 holding.
- AR Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- AR Asset Management's Zimmer Biomet position peaked at $1.08M in Q2 2021.
- 771 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on AR Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.